![Edward Lang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Lang
Corporate Officer/Principal chez
GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profil
Edward Lang is currently the Chief Business Officer at Gyroscope Therapeutics Holdings Plc since 2019.
Prior to this, he was the Vice President-Corporate Affairs at Juno Therapeutics, Inc. from 2017 to 2018.
Mr. Lang completed his undergraduate degree at LaSalle University.
Postes actifs de Edward Lang
| Sociétés | Poste | Début |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 01/06/2019 |
Anciens postes connus de Edward Lang
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/06/2018 |
Formation de Edward Lang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
